Published May 30, 2012

Executives View H-CAHPS as Greatest Value-Based Purchasing Challenge

In a recent HealthLeaders Media report — “Value-Based Purchasing: Facing the H-CAHPS Hurdle” — half of the executives surveyed admitted that they see H-CAHPS as the most difficult performance metric to improve under Value-Based Purchasing (“VBP”). “Heart failure” was a distant second at 16 percent, with other clinical process measures trailing far behind in the single digits.

Robert L. Clenning, Executive Vice President & CFO of Hackensack (NJ) University Medical Center and a member of the panel of executives interviewed for this report, observed, “… the gap between us and everyone else has gotten narrow. As we move from the process measures, which we’re really good at, to outcomes measures, which we’re not as good at as an industry, the game changes rather quickly.”

In the short-term, the 173 executives who participated in the survey are not optimistic regarding their organizations’ potential to achieve the relatively higher care process and H-CAHPS scores that would result in greater incentive payments than the initial 1 percent reduction in Diagnosis Related Group (DRG) reimbursement they face beginning October 1, 2012. Only 21 percent expect a net gain from value-based purchasing, while 30 percent anticipate a net loss.

To discuss ways PYA can help your institution improve performance under value-based purchasing or would like to request a speaker on this topic for your organization, contact one of our executives listed below, (800) 270-9629.

 

Interested in Learning More?

Sign Up for Our Latest Thought Leadership!



    Select Your Subscriptions